[1]
Prima Sanjiwani Saraswati Sudarsa, Mario Korwa and Nyoman Suryawati 2026. Therapeutic Outcomes of Secukinumab 300 mg in Severe Psoriasis Vulgaris with Metabolic Comorbidities: A Retrospective Cohort Study in Bali. Bioscientia Medicina : Journal of Biomedicine and Translational Research. 10, 4 (Jan. 2026), 1048-1096. DOI:https://doi.org/10.37275/bsm.v10i4.1552.